Treating pyrazinamide mono-resistant pulmonary tuberculosis.

Carlos, Pérez-Guzmán; Mario H, Vargas; Cindy P, Pérez-Arellano; Diana, García-Toledo

Found an issue? Give us feedback

The International Jo...arrow_drop_down

The International Journal of Tuberculosis and Lung Disease

Article . 2014

Data sources: Europe PubMed Central

Treating pyrazinamide mono-resistant pulmonary tuberculosis.

descriptionPublicationkeyboard_double_arrow_right Article 28 Feb 2014 English Journal:The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, volume 17 (issn: 1815-7920,

Copyright policy )

Authors: Carlos, Pérez-Guzmán; Mario H, Vargas; Cindy P, Pérez-Arellano; Diana, García-Toledo;

pmid: 23928174

Treating pyrazinamide mono-resistant pulmonary tuberculosis.

- Summary
- Subjects
- Metrics

No summary information available

Keywords

Adult, Male, Adolescent, Antitubercular Agents, Microbial Sensitivity Tests, Mycobacterium tuberculosis, Middle Aged, Pyrazinamide, Young Adult, Treatment Outcome, Child, Preschool, Drug Resistance, Bacterial, Humans, Drug Therapy, Combination, Female, Child, Tuberculosis, Pulmonary

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average